Gail Lynn Shaw Wright
AuthID: R-00J-P2R
1
TITLE: SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) plus Ctx versus trastuzumab (T) plus Ctx in patients (pts) with pretreated HER2+metastatic (met) breast cancer (MBC).
AUTHORS: Santiago Escriva; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; William John Gradishar; Mark D Pegram; Gail Lynn Shaw Wright; Christelle Levy; Michelino De laurentiis; Jean Marc Ferrero; Shakeela Wazeen Bahadur; Sung Bae Kim; Katarina Petrakova; David A Riseberg; Denise A Yardley; Sutton Edlich; Sam Hong; Edwin P Rock; Hope S Rugo;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
AUTHORS: Santiago Escriva; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; William John Gradishar; Mark D Pegram; Gail Lynn Shaw Wright; Christelle Levy; Michelino De laurentiis; Jean Marc Ferrero; Shakeela Wazeen Bahadur; Sung Bae Kim; Katarina Petrakova; David A Riseberg; Denise A Yardley; Sutton Edlich; Sam Hong; Edwin P Rock; Hope S Rugo;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
INDEXED IN: 
WOS
WOS